InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bicara Therapeutics Inc.

BCAX Clue Score37
United States Fiscal year ends December CIK 0002023658
$17.33 -0.97% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $17.33 −6.37% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Sep 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2023Operating income−39.9Net income−52.0EPS, diluted−89.61Fiscal year 2024Operating income−82.4Net income−68.0EPS, diluted−4.05Fiscal year 2025Operating income−155.6Net income−138.0EPS, diluted−2.52
FY2023FY2024FY2025
Operating income −39.9 −82.4 −155.6
Net income −52.0 −68.0 −138.0
Growth
EPS, diluted −89.61 −4.05 −2.52

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−45.6Capital expenditure−0.6Free cash flow−46.2Fiscal year 2024Operating cash flow−74.8Capital expenditure−0.1Free cash flow−74.8Fiscal year 2025Operating cash flow−106.8Capital expenditure−0.3Free cash flow−107.1
FY2023FY2024FY2025
Operating cash flow −45.6 −74.8 −106.8
Capital expenditure −0.6 −0.1 −0.3
Free cash flow −46.2 −74.8 −107.1
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash230.4Shareholders’ equity−148.8Fiscal year 2024Cash489.7Shareholders’ equity491.9Fiscal year 2025Cash96.7Shareholders’ equity401.5
FY2023FY2024FY2025
Cash 230.4 489.7 96.7
Shareholders’ equity −148.8 491.9 401.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −13.8% −34.4%
−22.2% −13.3% −32.0%
Balance and payout
6.6% 3.6% 6.9%